跳至主要内容
临床试验/NCT03639779
NCT03639779终止4 期

A Comparative Study of the Efficacy of Intralesional Sodium Thiosulfate Versus Intralesional Normal Saline for the Treatment of Dystrophic and Idiopathic Calcinosis Cutis, A Double-Blind Randomized Placebo-Controlled Trial

University of Central Florida1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2018年11月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
5
试验地点
1
主要终点
Visual Analog Scale (VAS) for Pain

研究概览

简要总结

The purpose of our research is to compare the effectiveness of 125mg/50ml sodium thiosulfate (STS) solution to normal saline (0.9% sodium chloride) when injected intralesionally for the treatment of calcinosis cutis. Our specific aim is to assess the response of dystrophic and idiopathic calcinosis cutis to the injections of sodium thiosulfate in our patients.

详细描述

Our specific aim is to assess the response of dystrophic and idiopathic calcinosis cutis to the injections of sodium thiosulfate in our patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female adult 18 years of age or older
  • Must have health insurance will be eligible to participate
  • Must have a current diagnosis of dystrophic or idiopathic calcinosis cutis
  • Subjects must have at least 2 lesions of at least 2mm in size

排除标准

  • Unable to read and speak English
  • Allergy to any component of the sodium thiosulfate solution
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Women who are breastfeeding
  • Prisoners

研究组 & 干预措施

Sodium thiosulfate

Experimental

50 ml vials of sodium thiosulfate (250mg/ml) will be used for treatment.

干预措施: Sodium Thiosulfate (Drug)

Saline solution

Placebo Comparator

30 ml vials of sodium chloride 0.9% will be used for the control treatment.

干预措施: Saline Solution (Other)

结局指标

主要结局

Visual Analog Scale (VAS) for Pain

时间窗: 3 months

The VAS for pain is used to assess the pain associated with the lesion. The pain will be recorded as a number from 1 (no pain) to 10 (severe pain).

Physician Global Assessment (PGA)

时间窗: 3 months

The PGA will be done by the physician to assess appearance and changes in the lesion. The lesion will be assigned a score from 0 (clear) to 4 (severe).

Lesion Size

时间窗: 3 months

The lesion size is measured in square centimeters.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Weinstein

Assistant Professor of Dermatology

University of Central Florida

研究点 (1)

Loading locations...

相似试验